Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Overview of attention for article published in Blood, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 33,393)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 67 news stories from 67 outlets.

Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic…

Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic…

--Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders -- Advertisement, /PR…

--Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders -- PHILADELPHIA, Nov.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 63 additional news stories.